Package 55154-0183-0

Brand: bupropion hydrochloride sr

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 55154-0183-0
Digits Only 5515401830
Product NDC 55154-0183
Description

10 BLISTER PACK in 1 BAG (55154-0183-0) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

Marketing

Marketing Status
Marketed Since 2025-06-09
Brand bupropion hydrochloride sr
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (0)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "439a7e93-f578-434f-943f-4b93c35450f5", "openfda": {"upc": ["0055154018302"], "unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["439a7e93-f578-434f-943f-4b93c35450f5"], "manufacturer_name": ["Cardinal Health 107, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "10 BLISTER PACK in 1 BAG (55154-0183-0)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "55154-0183-0", "marketing_start_date": "20250609"}], "brand_name": "bupropion hydrochloride SR", "product_id": "55154-0183_439a7e93-f578-434f-943f-4b93c35450f5", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "55154-0183", "generic_name": "bupropion hydrochloride", "labeler_name": "Cardinal Health 107, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA202304", "marketing_category": "ANDA", "marketing_start_date": "20250609", "listing_expiration_date": "20261231"}